Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis.
about
Normal and cancer stem cells of the human female reproductive systemEpigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen studyChanges in mouse uterine transcriptome in estrus and proestrus.Landscape of genomic alterations in cervical carcinomas.Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.Somatic Variations in Cervical Cancers in Indian Patients.Expression of Bmi-1, P16, and CD44v6 in Uterine Cervical Carcinoma and Its Clinical Significance.ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.).Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation.Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.Glycan-related gene expression signatures in breast cancer subtypes; relation to survival.Clinical Significance of CENP-H Expression in Uterine Cervical CancerDown-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell.Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.Novel Somatic Copy Number Alteration Identified for Cervical Cancer in the Mexican American PopulationIdentification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
P2860
Q26830842-D4073946-F604-4A11-AF1A-ED8042DE5A7AQ28390359-380AA68C-E916-480E-8F0A-0A9FAE0F0CE7Q33826070-39769BE3-ADE1-4129-A6F2-B8F991CEFF66Q34169464-02169276-A342-4DB1-9270-48EC5B40D636Q34658788-148C9D8D-DFB8-4F38-9C22-CF82DCDC5760Q36187364-9C017C87-A32D-40C6-B46A-BE6547CA37BDQ36814336-3D51E70F-D248-435D-A8E9-407B60D57107Q36994782-C918470E-D2D3-4BB3-8FC9-B182C07CB293Q37536775-E9E76B7E-11C6-4006-85C9-30A427A17EC0Q37578026-5014F216-7CCD-4FD4-881C-A7A69E6C006AQ38237693-327ED149-8F63-4D8E-86DA-A633F6BF6F47Q38946743-9D5F2F38-96E1-4F4B-B903-E51D3964326EQ39042751-2CD7098D-66CE-46CB-BB53-E873BEBCB131Q40369171-C889DFCD-C820-4654-A00C-9DABCC5526BBQ41384312-584063C3-EB3E-45CB-B1E3-DD06B6B6EE8DQ41676450-5D883398-72E1-46DF-86A9-E0B5ABDFE7E7Q42705595-F7877ECA-2034-4284-84C7-57A82D12B824Q53176174-F141B43F-BE80-4D6F-BB19-80F29BE7D7AE
P2860
Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Integrative genomic approaches ...... ns for molecular pathogenesis.
@ast
Integrative genomic approaches ...... ns for molecular pathogenesis.
@en
Integrative genomic approaches ...... ns for molecular pathogenesis.
@nl
type
label
Integrative genomic approaches ...... ns for molecular pathogenesis.
@ast
Integrative genomic approaches ...... ns for molecular pathogenesis.
@en
Integrative genomic approaches ...... ns for molecular pathogenesis.
@nl
prefLabel
Integrative genomic approaches ...... ns for molecular pathogenesis.
@ast
Integrative genomic approaches ...... ns for molecular pathogenesis.
@en
Integrative genomic approaches ...... ns for molecular pathogenesis.
@nl
P2860
P356
P1433
P1476
Integrative genomic approaches ...... ns for molecular pathogenesis.
@en
P2093
Gopeshwar Narayan
Vundavalli V Murty
P2860
P304
P356
10.2217/FON.10.114
P407
P577
2010-10-01T00:00:00Z